165 related articles for article (PubMed ID: 37792013)
1. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice.
Bosch AJT; Keller L; Steiger L; Rohm TV; Wiedemann SJ; Low AJY; Stawiski M; Rachid L; Roux J; Konrad D; Wueest S; Tugues S; Greter M; Böni-Schnetzler M; Meier DT; Cavelti-Weder C
Diabetologia; 2023 Dec; 66(12):2292-2306. PubMed ID: 37792013
[TBL] [Abstract][Full Text] [Related]
2. The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor.
Garceau V; Balic A; Garcia-Morales C; Sauter KA; McGrew MJ; Smith J; Vervelde L; Sherman A; Fuller TE; Oliphant T; Shelley JA; Tiwari R; Wilson TL; Chintoan-Uta C; Burt DW; Stevens MP; Sang HM; Hume DA
BMC Biol; 2015 Feb; 13():12. PubMed ID: 25857347
[TBL] [Abstract][Full Text] [Related]
3. CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages.
Lei F; Cui N; Zhou C; Chodosh J; Vavvas DG; Paschalis EI
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23336-23338. PubMed ID: 32900927
[TBL] [Abstract][Full Text] [Related]
4. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
5. Production and characterisation of a monoclonal antibody that recognises the chicken CSF1 receptor and confirms that expression is restricted to macrophage-lineage cells.
Garcia-Morales C; Rothwell L; Moffat L; Garceau V; Balic A; Sang HM; Kaiser P; Hume DA
Dev Comp Immunol; 2014 Feb; 42(2):278-85. PubMed ID: 24084378
[TBL] [Abstract][Full Text] [Related]
6. Reversible expansion of tissue macrophages in response to macrophage colony-stimulating factor (CSF1) transforms systemic lipid and carbohydrate metabolism.
Keshvari S; Masson JJR; Ferrari-Cestari M; Bodea LG; Nooru-Mohamed F; Tse BWC; Sokolowski KA; Batoon L; Patkar OL; Sullivan MA; Ebersbach H; Stutz C; Parton RG; Summers KM; Pettit AR; Hume DA; Irvine KM
Am J Physiol Endocrinol Metab; 2024 Feb; 326(2):E149-E165. PubMed ID: 38117267
[TBL] [Abstract][Full Text] [Related]
7. CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization.
Zhou Y; Zeng J; Tu Y; Li L; Du S; Zhu L; Cang X; Lu J; Zhu M; Liu X
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):37. PubMed ID: 33764399
[TBL] [Abstract][Full Text] [Related]
8.
Hawley CA; Rojo R; Raper A; Sauter KA; Lisowski ZM; Grabert K; Bain CC; Davis GM; Louwe PA; Ostrowski MC; Hume DA; Pridans C; Jenkins SJ
J Immunol; 2018 Mar; 200(6):2209-2223. PubMed ID: 29440354
[TBL] [Abstract][Full Text] [Related]
9. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.
McGillicuddy FC; Harford KA; Reynolds CM; Oliver E; Claessens M; Mills KH; Roche HM
Diabetes; 2011 Jun; 60(6):1688-98. PubMed ID: 21515850
[TBL] [Abstract][Full Text] [Related]
10. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
Rodrigues KB; Dufort MJ; Llibre A; Speake C; Rahman MJ; Bondet V; Quiel J; Linsley PS; Greenbaum CJ; Duffy D; Tarbell KV
Diabetologia; 2020 Aug; 63(8):1576-1587. PubMed ID: 32500289
[TBL] [Abstract][Full Text] [Related]
11. Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour.
Rosin JM; Vora SR; Kurrasch DM
Brain Behav Immun; 2018 Oct; 73():682-697. PubMed ID: 30056204
[TBL] [Abstract][Full Text] [Related]
12. CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy.
Battis K; Florio JB; Mante M; Lana A; Naumann I; Gauer C; Lambrecht V; Müller SJ; Cobo I; Fixsen B; Kim HY; Masliah E; Glass CK; Schlachetzki JCM; Rissman RA; Winkler J; Hoffmann A
J Neurosci; 2022 Oct; 42(40):7673-7688. PubMed ID: 36333098
[TBL] [Abstract][Full Text] [Related]
13. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
[TBL] [Abstract][Full Text] [Related]
14. Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
Yeung J; Yaghoobi V; Miyagishima D; Vesely MD; Zhang T; Badri T; Nassar A; Han X; Sanmamed MF; Youngblood M; Peyre M; Kalamarides M; Rimm DL; Gunel M; Chen L
Neuro Oncol; 2021 Nov; 23(11):1922-1935. PubMed ID: 33914067
[TBL] [Abstract][Full Text] [Related]
15. Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCε pathway in a rat model of neonatal HIE.
Hu X; Li S; Doycheva DM; Huang L; Lenahan C; Liu R; Huang J; Xie S; Tang J; Zuo G; Zhang JH
J Neuroinflammation; 2020 Jun; 17(1):182. PubMed ID: 32522286
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
17. The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice.
Merry TL; Brooks AES; Masson SW; Adams SE; Jaiswal JK; Jamieson SMF; Shepherd PR
Int J Obes (Lond); 2020 Jan; 44(1):245-253. PubMed ID: 30926949
[TBL] [Abstract][Full Text] [Related]
18. Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib.
Bellamri N; Morzadec C; Joannes A; Lecureur V; Wollin L; Jouneau S; Vernhet L
Int Immunopharmacol; 2019 Jul; 72():112-123. PubMed ID: 30974282
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
[TBL] [Abstract][Full Text] [Related]
20. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
Maldonado MDM; Schlom J; Hamilton DH
Cancer Immunol Immunother; 2023 Oct; 72(10):3349-3362. PubMed ID: 37505292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
